XTalks
NOVEMBER 9, 2023
The Alinity m high risk (HR) HPV assay is approved for HPV detection and use in routine cervical cancer screening as per professional medical guidelines, explained Abbott in a press release announcing the FDA approval. The Alinity m HR HPV assay was carefully designed to support patient care and streamline HPV testing.”
The Pharma Data
APRIL 7, 2021
months with chemotherapy (HR: 0.43; 95% CI: 0.35-0.54; months (HR: 0.51; 95% CI: 0.41-0.62; The incidence of Grade 3-4 neutropenia in genotyped patients was 69% in patients homozygous for the UGT1A1*28, 48% in patients heterozygous for the UGT1A1*28 allele and 46% in patients homozygous for the wild-type allele. months from 1.7
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
The Pharma Data
APRIL 14, 2021
Trodelvy is also being developed as an investigational treatment for hormone receptor-positive/human epidermal growth factor receptor 2-negative (HR+/HER 2-) metastatic breast cancer and metastatic non-small cell lung cancer. Beyond the regulatory approvals of Trodelvy in the U.S., About the TROPHY U-01 Study.
The Pharma Data
SEPTEMBER 2, 2021
Durvalumab ± Tremelimumab + Platinum-Etoposide in 1L ES-SCLC: Exploratory Analysis of HLA Genotype and Survival in CASPIAN. CAPItello-292: a phase 1b/3 study of capivasertib, palbociclib and fulvestrant versus placebo, palbociclib and fulvestrant in HR+/HER2-advanced breast cancer. Lead author. Abstract title. Presentation details.
The Pharma Data
NOVEMBER 24, 2020
0.514 mmol/24 hr/1.73 0.771 mmol/24 hr/1.73 Management options to date were limited to hyperhydration, crystallization inhibitors and, in a minority of patients with a specific genotype, pyridoxine (vitamin B6). Visit OXLUMO.com for more information, including full Prescribing Information. IMPORTANT SAFETY INFORMATION.
Expert insights. Personalized for you.
64 
Let's personalize your content